|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| Sep. 01 | Canaccord Genuity Initiates Aclaris Therapeutics at Buy With $10 Price Target | MT |
| Aug. 06 | Aclaris Therapeutics Gets Fast-Track Designation for Inflammation Treatment Modzatinib | DJ |
| Market Cap | 813M 704M 666M 603M 1.13B 78.01B 1.14B 7.95B 3.06B 39.56B 3.05B 2.99B 126B | P/E 2026 * |
-8.55x | P/E 2027 * | -7.02x |
|---|---|---|---|---|---|
| Enterprise Value | 660M 572M 541M 490M 919M 63.33B 926M 6.45B 2.48B 32.11B 2.48B 2.42B 102B | EV / Sales 2026 * |
104x | EV / Sales 2027 * | 125x |
| Free-Float |
97.82% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: ACLS THER
| Manager | Title | Age | Since |
|---|---|---|---|
Neal Walker
CEO | Chief Executive Officer | 56 | 2024-01-16 |
Hugh Davis
PSD | President | 67 | 2024-11-17 |
Kevin Balthaser
DFI | Director of Finance/CFO | 39 | 2022-12-31 |
| Director | Title | Age | Since |
|---|---|---|---|
Neal Walker
CHM | Chairman | 56 | 2022-12-31 |
Anand Mehra
BRD | Director/Board Member | 50 | 2014-08-31 |
| Director/Board Member | 59 | 2016-08-31 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -1.38% | +0.20% | +46.42% | +96.33% | 69.18B | |
| -0.37% | -1.11% | +35.68% | +75.26% | 62B | |
| -4.29% | -3.98% | -16.22% | +350.66% | 26.19B | |
| +1.46% | +2.25% | +28.84% | +14.54% | 25.75B | |
| -2.20% | -2.00% | -1.22% | -14.48% | 24.29B | |
| +3.84% | +4.36% | +25.50% | -14.44% | 19.84B | |
| +1.26% | -14.23% | +170.04% | +298.75% | 15.65B | |
| -5.54% | +0.69% | -8.13% | +830.48% | 13.88B | |
| -0.39% | -4.24% | -9.86% | +454.94% | 14.09B | |
| Average | -0.85% | -2.20% | +30.12% | +232.45% | 30.1B | |
| Weighted average by Cap. | -0.86% | -1.32% | +31.85% | +158.24% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 6.34M 5.49M 5.19M 4.7M 8.82M 608M 8.89M 61.95M 23.84M 308M 23.81M 23.28M 983M | 5.34M 4.62M 4.37M 3.96M 7.43M 512M 7.48M 52.17M 20.07M 260M 20.05M 19.61M 828M |
| Net income | -90.33M -78.24M -73.99M -66.98M -126M -8.66B -127M -883M -340M -4.39B -339M -332M -14.01B | -112M -97.31M -92.01M -83.3M -156M -10.78B -158M -1.1B -422M -5.46B -422M -413M -17.43B |
| Net Debt | -153M -133M -125M -114M -213M -14.69B -215M -1.5B -576M -7.45B -575M -562M -23.75B | -147M -127M -120M -109M -204M -14.06B -205M -1.43B -551M -7.13B -550M -538M -22.73B |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Select your edition
All financial news and data tailored to specific country editions
